Your browser doesn't support javascript.
loading
Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency.
Massimi, A; Malaponti, M; Federici, L; Vinciguerra, D; Manca Bitti, M L; Vottero, A; Ghizzoni, L; Maccarrone, M; Cappa, M; Bernardini, S; Porzio, O.
Afiliación
  • Massimi A; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Malaponti M; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Federici L; Department of Experimental and Clinical Sciences, Ce.S.I. Center of -Excellence on Aging, University of Chieti G. d'Annunzio, Chieti, Italy.
  • Vinciguerra D; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Manca Bitti ML; Pediatric Diabetology and Endocrinology Unit, Policlinico Tor Vergata, Rome, Italy.
  • Vottero A; Departments of Pediatrics, University of Parma, Parma, Italy.
  • Ghizzoni L; Division of Endocrinology, Diabetology, and Metabolism, Department of Internal Medicine, University of Turin, Turin, Italy.
  • Maccarrone M; Center of Integrated Research, Campus Bio-Medico University of Rome, Rome, Italy.
  • Cappa M; Endocrinology and Diabetology Unit and Research Laboratory, Bambino Gesù Children's Hospital, Rome, Italy.
  • Bernardini S; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Porzio O; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Horm Metab Res ; 46(7): 515-20, 2014 Jun.
Article en En | MEDLINE | ID: mdl-24799024
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder mainly caused by defects in the 21-hydroxylase gene (CYP21A2), coding for the enzyme 21-hydroxylase (21-OH). About 95% of the mutations arise from gene conversion between CYP21A2 and the inactive pseudogene CYP21A1P: only 5% are novel CYP21A2 mutations, in which functional analysis of mutant enzymes has been helpful to correlate genotype-phenotype. In the present study, we describe 3 novel point mutations (p.L122P, p.Q481X, and p.E161X) in 3 Italian patients with CAH: the fourth mutation (p.M150R) was found in the carrier state. Molecular modeling suggests a major impact on 21-hydroxylase activity, and functional analysis after expression in COS-7 cells confirms reduced enzymatic activity of the mutant enzymes. Only the p.M150R mutation affected the activity to a minor extent, associated with NC CAH. CYP21A2 genotyping and functional characterization of each disease-causing mutation has relevance both for treatment and genetic counseling to the patients.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esteroide 21-Hidroxilasa / Hiperplasia Suprarrenal Congénita / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Child / Female / Humans / Male / Newborn País/Región como asunto: Europa Idioma: En Revista: Horm Metab Res Año: 2014 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esteroide 21-Hidroxilasa / Hiperplasia Suprarrenal Congénita / Mutación Tipo de estudio: Prognostic_studies Límite: Animals / Child / Female / Humans / Male / Newborn País/Región como asunto: Europa Idioma: En Revista: Horm Metab Res Año: 2014 Tipo del documento: Article País de afiliación: Italia